Professional musicians experience high preoccupation levels, intense social exposure to their performance, and potential adverse reactions from the audience, leading to anxiety. These experiences constitute what is called music performance anxiety (MPA). MPA can be defined as a subtype of social anxiety tied to a specific performance condition.
Oxytocin is shown to have a potential therapeutic effect on cognitive processes, anxiety, and decreased psychosocial stress. Considering this, the research team aimed to examine the impact of a single dose of 24 UI of intranasal OXT in professional singers during a public singing simulation test on self-rated mood and performance.
For this purpose, the researchers assessed 54 male singers with different levels of musical performance anxiety (42% high) in a crossover, randomized, double-blinded, placebo-controlled trial. The participants participated in various phases of simulated public singing performance. They self-rated their performances and mood based. Data analysis was done using ANOVA 2 × 2 for crossover trials.
The study showed that oxytocin use during the performance and immediate post-stress led to more positive and less negative assessments of singing performance than the use of a placebo. The researchers did not find any treatment effects in any VAMS subscales, suggesting no direct anxiolytic effects.
"Oxytocin improved the self-perception of the participants during and immediately after their performance," the researchers wrote, underscoring the effect of OXT in the MPA's cognitive component of MPA, with a high size effect. "Given the negative and catastrophic thoughts related to MPA are common and lead to harm and suffering, with loss of quality of work and life, this finding is relevant."
To conclude, OXT can minimize social stress, particularly during performances.
Reference:
Osório FL, Espitia-Rojas GV and Aguiar-Ricz LN (2022) Effects of intranasal oxytocin on the self-perception and anxiety of singers during a simulated public singing performance: A randomized, placebo-controlled trial. Front. Neurosci. 16:943578. doi: 10.3389/fnins.2022.943578
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.